Phase I trial of fosnetupitant/palonosetron IV for the prevention of chemotherapy-induced nausea and vomiting in China
Latest Information Update: 18 Mar 2020
At a glance
- Drugs Netupitant/palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions
Most Recent Events
- 18 Mar 2020 New trial record